Alchemy Chiropractic Llc | |
251 Us 1 Suite W17 Falmouth ME 04105-0410 | |
(207) 613-9424 | |
Not Available |
Full Name | Alchemy Chiropractic Llc |
---|---|
Speciality | Clinic/Center |
Location | 251 Us 1 Suite W17, Falmouth, Maine |
Authorized Official Name and Position | Sergey Terrio (OWNER) |
Authorized Official Contact | 2076924730 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Alchemy Chiropractic Llc 251 Us 1 Suite W17 Falmouth ME 04105 Ph: (207) 613-9424 | Alchemy Chiropractic Llc 251 Us 1 Suite W17 Falmouth ME 04105-0410 Ph: (207) 613-9424 |
NPI Number | 1962086389 |
---|---|
Provider Enumeration Date | 05/11/2021 |
Last Update Date | 07/13/2021 |
Medicare PECOS PAC ID | 4981006012 |
---|---|
Medicare Enrollment ID | O20210713001041 |
News Archive
In response to an article published by Chinese scientists describing research that used gene editing technologies in human embryos, the International Society for Stem Cell Research has again called for a moratorium on attempts at human clinical germline genome editing while extensive scientific analysis of the potential risks is conducted, along with broad public discussion of the societal and ethical implications.
Enzo Biochem, Inc. (NYSE: ENZ), announced today that it had entered into a Cooperative Research and Development Agreement (CRADA) with the National Eye Institute, part of the National Institute of Health, to conduct a human clinical trial of Optiquelâ„¢, Enzo's oral, proprietary therapeutic for chronic autoimmune uveitis.
With the mosquito season virtually upon us, there is growing concern about the potential for the Zika virus to spread in the United States. In fact, many public health officials believe it is not a question of if but rather when an outbreak will occur here.
Evidence shows that coronavirus disease (COVID-19) most often affects older adults, who are 60 years old or more, and those with underlying medical conditions. But a new study has shown that several children in China had developed severe or critical conditions, with one child dying from COVID-19.
A new statement by the American College of Medical Genetics and Genomics (ACMG), published in the journal Genetics in Medicine, discusses the place of germline genetic testing in breast cancer patients.
› Verified 1 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1962086389 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261Q00000X | Clinic/center | (* (Not Available)) | Primary |
Provider Name | Sergey Terrio |
---|---|
Provider Type | Practitioner - Chiropractic |
Provider Identifiers | NPI Number: 1922691187 PECOS PAC ID: 5890197925 Enrollment ID: I20210713001737 |
News Archive
In response to an article published by Chinese scientists describing research that used gene editing technologies in human embryos, the International Society for Stem Cell Research has again called for a moratorium on attempts at human clinical germline genome editing while extensive scientific analysis of the potential risks is conducted, along with broad public discussion of the societal and ethical implications.
Enzo Biochem, Inc. (NYSE: ENZ), announced today that it had entered into a Cooperative Research and Development Agreement (CRADA) with the National Eye Institute, part of the National Institute of Health, to conduct a human clinical trial of Optiquelâ„¢, Enzo's oral, proprietary therapeutic for chronic autoimmune uveitis.
With the mosquito season virtually upon us, there is growing concern about the potential for the Zika virus to spread in the United States. In fact, many public health officials believe it is not a question of if but rather when an outbreak will occur here.
Evidence shows that coronavirus disease (COVID-19) most often affects older adults, who are 60 years old or more, and those with underlying medical conditions. But a new study has shown that several children in China had developed severe or critical conditions, with one child dying from COVID-19.
A new statement by the American College of Medical Genetics and Genomics (ACMG), published in the journal Genetics in Medicine, discusses the place of germline genetic testing in breast cancer patients.
› Verified 1 days ago
News Archive
In response to an article published by Chinese scientists describing research that used gene editing technologies in human embryos, the International Society for Stem Cell Research has again called for a moratorium on attempts at human clinical germline genome editing while extensive scientific analysis of the potential risks is conducted, along with broad public discussion of the societal and ethical implications.
Enzo Biochem, Inc. (NYSE: ENZ), announced today that it had entered into a Cooperative Research and Development Agreement (CRADA) with the National Eye Institute, part of the National Institute of Health, to conduct a human clinical trial of Optiquelâ„¢, Enzo's oral, proprietary therapeutic for chronic autoimmune uveitis.
With the mosquito season virtually upon us, there is growing concern about the potential for the Zika virus to spread in the United States. In fact, many public health officials believe it is not a question of if but rather when an outbreak will occur here.
Evidence shows that coronavirus disease (COVID-19) most often affects older adults, who are 60 years old or more, and those with underlying medical conditions. But a new study has shown that several children in China had developed severe or critical conditions, with one child dying from COVID-19.
A new statement by the American College of Medical Genetics and Genomics (ACMG), published in the journal Genetics in Medicine, discusses the place of germline genetic testing in breast cancer patients.
› Verified 1 days ago
Fal River Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 202 Route 1, Suite 203, Falmouth, ME 04105 Phone: 207-781-7880 Fax: 207-781-7882 | |
Falmouth Internal Medicine Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 170 Us Route 1, Suite G, Falmouth, ME 04105 Phone: 207-781-7778 Fax: 207-781-7779 |